• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial.

作者信息

Swirski Filip K

机构信息

Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts 02114, USA.

出版信息

Nat Rev Cardiol. 2018 Feb;15(2):79-80. doi: 10.1038/nrcardio.2017.208. Epub 2017 Dec 21.

DOI:10.1038/nrcardio.2017.208
PMID:29263444
Abstract
摘要

相似文献

1
Inflammation and CVD in 2017: From clonal haematopoiesis to the CANTOS trial.2017年的炎症与心血管疾病：从克隆性造血到CANTOS试验
Nat Rev Cardiol. 2018 Feb;15(2):79-80. doi: 10.1038/nrcardio.2017.208. Epub 2017 Dec 21.
2
Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.临床医生减少炎症以降低动脉粥样硬化血栓形成风险指南：JACC 每周综述专题。
J Am Coll Cardiol. 2018 Dec 25;72(25):3320-3331. doi: 10.1016/j.jacc.2018.06.082. Epub 2018 Nov 8.
3
Immunotherapy for cardiovascular disease.免疫疗法治疗心血管疾病。
Eur Heart J. 2019 Dec 21;40(48):3937-3946. doi: 10.1093/eurheartj/ehz283.
4
Inflammation and Atherosclerosis: The End of a Controversy.炎症与动脉粥样硬化：争议的终结
Circulation. 2017 Nov 14;136(20):1875-1877. doi: 10.1161/CIRCULATIONAHA.117.030484. Epub 2017 Sep 15.
5
Clinical approach to the inflammatory etiology of cardiovascular diseases.心血管疾病炎症病因的临床研究方法
Pharmacol Res. 2020 Sep;159:104916. doi: 10.1016/j.phrs.2020.104916. Epub 2020 May 20.
6
Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis.造血功能紊乱与心血管疾病：以髓系造血为例。
Clin Sci (Lond). 2018 Sep 5;132(17):1889-1899. doi: 10.1042/CS20180111. Print 2018 Sep 14.
7
Body fat and metabolic age as indicators of inflammation and cardiovascular risk.身体脂肪和代谢年龄作为炎症和心血管风险的指标。
Eur J Prev Cardiol. 2018 Feb;25(3):233-234. doi: 10.1177/2047487317744051. Epub 2017 Nov 22.
8
Colchicine in coronary disease: another renaissance of an ancient drug.秋水仙碱与冠心病：一种古老药物的再度复兴
Cardiovasc Res. 2021 Jan 1;117(1):e4-e6. doi: 10.1093/cvr/cvaa342.
9
Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.高脂血症与动脉粥样硬化中的炎症相互作用：将实验靶点转化为临床实践。
Eur J Prev Cardiol. 2018 Jun;25(9):948-955. doi: 10.1177/2047487318773384. Epub 2018 May 14.
10
Targeting the immune response in atherosclerosis: It's time for clinical trials!针对动脉粥样硬化中的免疫反应：开展临床试验的时候到了！
Arch Cardiovasc Dis. 2017 Dec;110(12):643-645. doi: 10.1016/j.acvd.2017.08.001. Epub 2017 Oct 16.

引用本文的文献

1
At the heart of the matter: how mental stress and negative emotions affect atrial fibrillation.问题的核心：心理压力和负面情绪如何影响心房颤动。
Front Cardiovasc Med. 2023 Jun 20;10:1171647. doi: 10.3389/fcvm.2023.1171647. eCollection 2023.
2
Clonal haematopoiesis and atherosclerotic cardiovascular disease.克隆性造血与动脉粥样硬化性心血管疾病
Nat Rev Cardiol. 2023 Jul;20(7):437-438. doi: 10.1038/s41569-023-00882-2.
3
Pyroptosis in development, inflammation and disease.细胞焦亡在发育、炎症和疾病中的作用。

本文引用的文献

1
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.卡那单抗治疗后 C 反应蛋白降低与心血管事件减少的关系：来自 CANTOS 随机对照试验的二次分析。
Lancet. 2018 Jan 27;391(10118):319-328. doi: 10.1016/S0140-6736(17)32814-3. Epub 2017 Nov 13.
2
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
3
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Front Immunol. 2022 Sep 16;13:991044. doi: 10.3389/fimmu.2022.991044. eCollection 2022.
4
Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients.骨髓增生异常综合征患者铁螯合治疗的预后因素及临床考量
J Blood Med. 2021 Dec 3;12:1019-1030. doi: 10.2147/JBM.S287876. eCollection 2021.
5
Clonal Hematopoiesis of Indeterminate Potential: an Expanding Genetic Cause of Cardiovascular Disease.克隆性造血：心血管疾病不断扩展的遗传病因。
Curr Atheroscler Rep. 2021 Sep 1;23(11):66. doi: 10.1007/s11883-021-00966-9.
6
Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice.重症新型冠状病毒肺炎：了解免疫、内皮及凝血在临床实践中的作用
J Vasc Bras. 2020 Nov 16;19:e20200131. doi: 10.1590/1677-5449.200131.
7
Inflammasomes as therapeutic targets in human diseases.炎症小体作为人类疾病的治疗靶点。
Signal Transduct Target Ther. 2021 Jul 2;6(1):247. doi: 10.1038/s41392-021-00650-z.
8
What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics.向患有克隆性造血的患者告知什么及原因：来自 2 家专业诊所的见解。
Blood. 2020 Oct 1;136(14):1623-1631. doi: 10.1182/blood.2019004291.
9
Controversies on the Consequences of Iron Overload and Chelation in MDS.骨髓增生异常综合征中铁过载及螯合治疗后果的争议
Hemasphere. 2020 May 27;4(3):e357. doi: 10.1097/HS9.0000000000000357. eCollection 2020 Jun.
10
Anemia in the Elderly.老年人贫血
Hemasphere. 2018 Apr 17;2(3):e40. doi: 10.1097/HS9.0000000000000040. eCollection 2018 Jun.
克隆性造血与动脉粥样硬化性心血管疾病风险
N Engl J Med. 2017 Jul 13;377(2):111-121. doi: 10.1056/NEJMoa1701719. Epub 2017 Jun 21.
4
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.与TET2缺陷相关的克隆性造血加速小鼠动脉粥样硬化发展。
Science. 2017 Feb 24;355(6327):842-847. doi: 10.1126/science.aag1381. Epub 2017 Jan 19.
5
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
6
Atherosclerosis is an inflammatory disease.动脉粥样硬化是一种炎症性疾病。
Am Heart J. 1999 Nov;138(5 Pt 2):S419-20. doi: 10.1016/s0002-8703(99)70266-8.
7
Atherosclerosis--an inflammatory disease.动脉粥样硬化——一种炎症性疾病。
N Engl J Med. 1999 Jan 14;340(2):115-26. doi: 10.1056/NEJM199901143400207.